Despite the need, there are no FDA-approved medications to treat cannabis use disorder. AEF0117 is the first of a new pharmacologic class, type 1 cannabinoid receptor signaling-specific inhibitors ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results